¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"zinc alloy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • silver copper alloy
    Àº±¸¸®ÇÕ±Ý
  • silver palladium alloy
    ÀºÆÈ¶óµãÇÕ±Ý
  • silver tin alloy
    ÀºÁÖ¼®ÇÕ±Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • silver palladium alloy
    ÀºÆÈ¶óµãÇÕ±Ý
  • silver tin alloy
    ÀºÁÖ¼®ÇÕ±Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • light alloy
    °æÇÕ±Ý(ÌîùêÐÝ).
  • pyrophoric alloy =pyrophorous a.
    ¹ßÈ­ÇÕ±Ý(Û¡ûýùêÐÝ).
  • resistance limit of gold alloy
    ±ÝÇձݳ»»êÇѵµ(ÐÝùêÐÝұ߫ùÚöô).
  • silver alloy for inlay
    Àη¹ÀÌ¿ë ÀºÇÕ±Ý(¡­éÄëÞùêÐÝ).
  • silver copper alloy
    Àºµ¿ÇÕ±Ý(¡­ùêÐÝ).
  • silver palladium alloy
    Àº-ÆÈ¶óµãÇÕ±Ý.
  • silver tin alloy
    Àº-ÁÖ¼®ÇÕ±Ý(ëÞñ¹à¸ùêÐÝ).
  • spherical alloy
    ±¸»óÇÕ±Ý(ϹßÒùêÐÝ).
  • crystalline zinc insulin
    °áÁ¤¼º ¾Æ¿¬(Ì¿ïÜàõ䬿ç)Àν¶¸°.
  • erythrocyte zinc protoporphyrin
    ÀûÇ÷±¸¾Æ¿¬ÇÁ·ÎÅäÆ÷¸£ÇǸ°
  • formalin-zinc sulfate flotation procedure
    Æ÷¸£¸»¸°È²»ê¾Æ¿¬ºÎ¾ç¹æ¹ý
  • insulin zinc suspension
    Àν¶¸°¾Æ¿¬Çöʾ×.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • protamin(e) zinc insulin
    ÇÁ·ÎŸ¹Î¾Æ¿¬ Àν¶¸°.
  • stomatitis, zinc
    ¾Æ¿¬(¼º) ±¸³»¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AZGP zinc-alpha-2-glycoprotein
Czn zinc clearance
IPZ insulin protamine zinc
PLZF promyelocytic leukemia zinc finger
PZ pancreozymin; pregnancy zone; proliferative zone; protamine zinc
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Cu,Zn-SOD Copper-zinc SOD
PLZF Promyelocytic leukemia zinc finger
SZL Serum zinc level
Zn2+ Zinc
ZIO Zinc Iodide Osmium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • zinc phosphate cement base
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ® ÀÌÀå
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ®¸¦ »ç¿ëÇÏ¿© Ä¡¾Æ¿¡ Çü¼ºÇÑ ¿Íµ¿¿¡ base¸¦ ±î´Â °Í.
  • zinc polycarboxylate cement
    ¾Æ¿¬ Æú¸®Ä«º¹½Ç·¹ÀÌÆ® ½Ã¸àÆ®
    »êÈ­ ¾Æ¿¬°ú Æú¸®¾ÆÅ©¸±»ê ¼ö¿ë¾×À» ¿¬È­ÇÏ¿© °æÈ­ÇÏ´Â Ä¡°ú¿ë ½Ã¸àÆ®.
  • zinc protoporphyrin
    ¾Æ¿¬ ÇÁ·ÎÅäÆ÷¸£ÇǸ°
  • zinc sulfate
    Ȳ»ê ¾Æ¿¬
    ¹«»ö, Åõ¸íÇÑ °áÁ¤Ã¼, ZnSO
  • zinc sulfate flotation procedure
    Ȳ»ê ¾Æ¿¬ ºÎ¾ç¹ý
  • admixed high-copper alloy
    È¥ÇÕÇü °íµ¿ÇÕ±Ý
    °íµ¿ÇÕ±ÝÀÇ °¡Àå ¿À·¡µÈ ÇüÅ·μ­ Àº, ÁÖ¼®, 6% ÀÌÇÏÀÇ ±¸¸®¸¦ ÇÔÀ¯ÇÑ Àç·¡Çü Àúµ¿ÇԱݰú ´ë°Ô ±¸¸®°¡ ¸¹Àº Àº-±¸¸® °øÁ¤ ÇÕ±ÝÀÇ µÎ °¡Áö ºÐ¸»À» È¥ÇÕÇÏ¿© ±¸¸®ÀÇ ÃÑ·®À» Áõ°¡½ÃŲ °ÍÀÌ´Ù. Àúµ¿ Àç·¡Çü ÇÕ±ÝÀº Àý»èÇüÀÌ¸ç °íµ¿ÇÕ±ÝÀº ±¸»óÇüÀ̾ °á°úÀûÀ¸·Î Àý»èÇü°ú ±¸»óÇüÀÌ È¥ÇÕµÈ °ÍÀÌ´Ù.
  • alloy backing
    ÇÕ±Ý ÀÌÀå
  • alloy system
    Çձݰè
  • amalgam alloy
    ¾Æ¸»°¨ ÇÕ±Ý
  • base metal alloy
    ºñ±Í±Ý¼Ó ÇÕ±Ý
  • binary alloy
    ÀÌ¿ø ÇÕ±Ý
  • comminuted alloy
    Àý»è ÇÕ±Ý
  • economy alloy
    Àú±Í±Ý¼Ó ÇÕ±Ý, °æÁ¦¼º ÇÕ±Ý
  • heat resisting alloy
    ³»¿­ ÇÕ±Ý
    °í¿Â¿¡¼­ È­ÇÐÀû, ¹°¸®ÀûÀ¸·Î ¾ÈÁ¤µÇ°í ¶Ç ±â°èÀû ¼ºÁúÀÌ ¶Ù¾î³ª °í¿Â¿¡¼­ÀÇ »ç¿ë¿¡ °ßµð´Â Á¶°ÇÀ» ±¸ºñÇÏ´Â ÇÕ±Ý.
  • inlay casting alloy
    Àη¹ÀÌ ÁÖÁ¶¿ë ÇÕ±Ý
    Àη¹ÀÌ¿ëÀ¸·Î ¾²ÀÌ´Â ÇÕ±ÝÀ» ¶æÇÏÁö¸¸ µû·Î Àη¹ÀÌ¿ë ÇÕ±ÝÀ̶õ °ÍÀÌ ÀÖ´Â °ÍÀº ¾Æ´Ï¸ç Ä¡°ú¿ë ÇÕ±ÝÀº ¾î´À °ÍÀ̳ª ÀÌ ¸ñÀû¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
insulin, protamine zinc <chemical> A long-acting insulin with an approximate time of onset of 7 hours and duration of action 36 hours, consisting of bovine or pork insulin reacted with zinc chloride and protamine to form a protein complex from which insulin is slowly released.
Pharmacological action: hypoglycaemic agents.
Chemical name: Insulin protamine zinc
(12 Dec 1998)
insulin zinc suspension A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin.
Synonym: lente insulin.
(05 Mar 2000)
extended insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
zinc <chemistry, element> An essential trace element being an essential component of the active site of a variety of enzymes.
Zinc has a high affinity for the side chains of cysteine and histidine. Zinc is present in tissues at levels of 0.1mM, but intracellular levels must be much lower.
Abbreviation: Zn
(18 Nov 1997)
zinc-65 A radioactive zinc isotope that decays mainly by K-capture with a half-life of 243.8 days; used as a tracer in studies of zinc metabolism.
(05 Mar 2000)
zinc acetate <chemical> A salt produced by the reaction of zinc oxide with acetic acid. It is used as a pharmaceutic necessity for zinc-eugenol cement and also as an astringent, styptic, and formerly as an emetic.
Pharmacological action: astringents, pharmaceutic aid.
(12 Dec 1998)
zinc arsenate <chemical> A toxic compound of zinc and arsenic which is used as an insecticide and to preserve timber from decay.
(11 May 1997)
zinc caprylate A topical antifungal compound.
(05 Mar 2000)
zinc chloride ZnCl2;formerly used as a caustic for the removal of cutaneous cancers, nevi, etc., and in weak solution in the treatment of gonorrhoea and conjunctivitis.
Synonym: butter of zinc.
(05 Mar 2000)
zinc colic Colic resulting from chronic zinc poisoning.
(05 Mar 2000)
zinc compounds Inorganic compounds that contain zinc as an integral part of the molecule.
(12 Dec 1998)
zinc D-Ala-D-Ala carboxypeptidase <enzyme> Involved in last step of peptidoglycan synthesis; resistant to penicillin; see also record for d-alanyl-d-alanine serine peptidases
Registry number: EC 3.4.17.14
Synonym: d-alanyl-d-alanine peptidase, zn(2+)g, zn(2+)g d-ala-d-ala peptidase, zn-ala-ala peptidase, zn(2+)g d-alanyl-d-alanine peptidase
(26 Jun 1999)
zinc deficiency : Deficiency of zinc is associated with short stature, anaemia, increased pigmentation of skin (hyperpigmentation), enlarged liver and spleen (hepatosplenomegaly), impaired gonadal function (hypogonadism), impaired wound healing, and immune deficiency. (for a genetic disorder that impairs zinc uptake, please see acrodermatitis enteropathica). According to the national academy of sciences, the recommended dietary allowances of zinc are 12 milligrams per day for women and 10 milligrams per day for men. Food sources of zinc include meat including liver, eggs, seafood, nuts and cereal.
(12 Dec 1998)
zinc deficiency dermatitis and diarrhoea A genetic disease called acrodermatitis enteropathica is characterised by the simultaneous occurrence of skin inflammation (dermatitis) and diarrhoea. The skin on the cheeks, elbows and knees and tissue about the mouth and anus are inflammed. There is also balding of the scalp, eyebrows and lashes, delayed wound healing and recurrent bacterial and fungal infections due to immune deficiency. The key laboratory finding is an abnormally low blood zinc level reflecting impaired zinc uptake. Oral treatment with zinc is curative.
(12 Dec 1998)
zinc excess Too much zinc can cause gastrointestinal irritation (upset stomach), interfere with copper absorption and cause copper deficiency, and (like too little zinc) cause immune deficiency. According to the national academy of sciences, the recommended dietary allowances of zinc are 12 milligrams per day for women and 10 milligrams per day for men.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á